Keap/Nrf2 is also one of the key mechanisms in the NO metabolic pathway, and plays an important role in vascular smooth muscle injury, endothelial dysfunction, and arteriosclerosis [46]. The gene discussed is NFE2L2; the disease is arteriosclerosis disorder.